Secondary bacterial infections & extensively drug-resistant bacteria among COVID-19 hospitalized patients at the University Hospital in Kraków

Table 3 Extensively drug-resistant strain prevalence in COVID-19 patients at UHK

XDR prevalence according to selected factors [%]	XDR		p-value
XDR prevalence according to selected factors [%]	No	Yes	p-value
Age median (Q1;Q3) [years]	69 (63;75)	66 (63;73)	0.106
HAIs N [%]
PNA	78 (66.1%)	40 (33.9%)	0.008
UTI	107 (79.9%)	27 (20.1%)
BSI	48 (87.3%)	7 (12.7%)
Others	14 (82.4%)	3 (17.6%)
ICU N [%]
Yes	196 (75.1%)	65 (24.9%)	0.415
No	51 (81.0%)	12 (19.0%)	0.415
Sex N [%]
Female	103 (83.1%)	21 (16.9%)	0.029
Male	142 (71.7%)	56 (28.3%)	0.029
Etiological factors N [%]
Staphylococcus aureus	36 (100.0%)	0 (0.0%)	< 0.001
Enterococcus spp.	60 (100.0%)	0 (0.0%)
Escherichia coli	45 (100.0%)	0 (0.0%)
Klebsiella spp.	32 (75.0%)	11 (25.0%)
Acinetobacter spp	12 (19.0%)	51 (81.0%)
Others	55 (80.9%)	13 (19.1%)

Legend: BSI: bloodstream infection; HAI: healthcare-associated infections; ICU: intensive care unit; PNA: pneumonia; UTI: urinary tract infection; Q1: first quartile; Q3: third quartile; XDR: extensively drug-resistant; UHK: University Hospital in Kraków

ISSN: 1476-0711